Role of Pathologic Shear Stress Alterations in Aortic Valve Endothelial Activation
- 122 Downloads
Calcific aortic stenosis is the most common aortic valve (AV) disease and is triggered by an active inflammatory process involving endothelial activation and cytokine expression. Interfacing between the leaflet and the surrounding blood flow, shear stress is presumed to play an important role in endothelial injury. This study investigated the hypothesis that pathologic alterations in shear stress magnitude contribute to valvular endothelial activation via BMP-4- and TGF-β1-dependent mechanisms. The fibrosa of porcine AV leaflets was subjected to physiologic, sub-physiologic and supra-physiologic magnitudes of native oscillatory shear stress for 48 h. Endothelial activation was assessed via immunohistochemistry in terms of ICAM-1 and VCAM-1 expressions. Cytokine expression was investigated in terms of BMP-4 and TGF-β1. Pro- and anti-osteogenic media were used to characterize the role of those cytokines in the shear stress-induced pathological response. Supra-physiologic shear stress increased the expression of all biomarkers in a shear stress magnitude-dependent manner. In contrast, neither physiologic nor sub-physiologic shear stress elicited a pro-inflammatory response. While BMP-4 inhibition and supplementation had limited effects on endothelial activation, TGF-β1 supplementation increased the overall leaflet pro-inflammatory state and TGF-β1 inhibition reduced endothelial activation in response to elevated shear stress. Combined TGF-β1 and BMP-4 inhibition completely suppressed shear stress-induced endothelial activation. The results demonstrate that elevated shear stress activates the valvular endothelium on the fibrosa via a BMP-4- and TGF-β1-dependent pathway. The suggested synergy between those cytokines also provides new insights into the transduction of valvular hemodynamic alterations into a pathological response.
KeywordsAortic valve Endothelial activation Shear stress Cytokines Adhesion molecules
The authors thank Steven DeLaurentis and Michael O’Connor (University of Notre Dame) for their assistance with the experiments, Leon Hluchota (University of Notre Dame) for his advice on the bioreactor design and fabrication, and Martin’s Custom Butchering (Wakarusa, IN) for supplying porcine hearts. This work was supported by the Faculty Research Program at the University of Notre Dame.
- 3.Balachandran, K., P. Sucosky, H. Jo, and A. P. Yoganathan. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. Am. J. Pathol., 2010. doi:10.2353/ajpath.2010.090631.
- 10.Clark-Greuel, J. N., J. M. Connolly, E. Sorichillo, N. R. Narula, H. S. Rapoport, E. R. Mohler, III, J. H. Gorman, III, R. C. Gorman, and R. J. Levy. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann. Thorac. Surg. 83:946–953, 2007.CrossRefGoogle Scholar
- 17.Harasaki, H., H. Hanano, J. Tanaka, K. Tokunaga, and M. Torisu. Surface structure of the human cardiac valve. A comparative study of normal and diseased valves. J. Cardiovasc. Surg. (Torino) 19:281–290, 1978.Google Scholar
- 18.Inman, G. J., F. J. Nicolas, J. F. Callahan, J. D. Harling, L. M. Gaster, A. D. Reith, N. J. Laping, and C. S. Hill. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:65–74, 2002.CrossRefGoogle Scholar
- 20.Jian, B., N. Narula, Q. Y. Li, E. R. Mohler, III, and R. J. Levy. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann. Thorac. Surg. 75:457–465, 2003; (discussion 465–6).CrossRefGoogle Scholar
- 22.Kaden, J. J., S. Bickelhaupt, R. Grobholz, C. F. Vahl, S. Hagl, M. Brueckmann, K. K. Haase, C. E. Dempfle, and M. Borggrefe. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J. Heart Valve Dis. 13:560–566, 2004.Google Scholar
- 25.Laping, N. J., E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan, and B. A. Olson. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62:58–64, 2002.CrossRefGoogle Scholar
- 26.Lee, Y. S., and Y. Y. Chou. Pathogenetic mechanism of senile calcific aortic stenosis: the role of apoptosis. Chin. Med. J. (Engl) 111:934–939, 1998.Google Scholar
- 29.Mohler, III, E. R., M. K. Chawla, A. W. Chang, N. Vyavahare, R. J. Levy, L. Graham, and F. H. Gannon. Identification and characterization of calcyfying cells from human and canine aortic valves. J. Heart Valve Dis. 8:254–260, 1999.Google Scholar
- 30.Mohler, III, E. R., F. Gannon, C. Reynolds, R. Zimmerman, M. G. Keane, and F. S. Kaplan. Bone formation and inflammation in cardiac valves. Circulation 103:1522–1528, 2001.Google Scholar
- 32.O’Brien, K. D., D. D. Reichenbach, S. M. Marcovina, J. Kuusisto, C. E. Alpers, and C. M. Otto. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler. Thromb. Vasc. Biol. 16:523–532, 1996.Google Scholar
- 34.Otto, C. M., J. Kuusisto, and D. D. Reichenbach. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90:844–853, 1994.Google Scholar
- 36.Platt, M. O., Y. Xing, H. Jo, and A. P. Yoganathan. Cyclic pressure and shear stress regulate matrix metalloproteinases and cathepsin activity in porcine aortic valves. J. Heart Valve Dis. 15:622–629, 2006.Google Scholar
- 51.Willems, I. E., M. G. Havenith, J. F. Smits, and M. J. Daemen. Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab. Invest. 71:127–133, 1994.Google Scholar